Eribulin

Overview

Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer . Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > ADC Payloads

Product Information

• Catalog No.: HY-13442
• CAS No.: 253128-41-5
• Molecular Formula: C40H59NO11
• Molecular Weight: 729.90
• Purity: 99.46%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Solubility: ≥ 5 mg/mL (6.85 mM); Clear solution
• Availability: In-stock

Source

Original product source